BioSpace News Archive

Technological advancements and a rise in the prevalence of ophthalmic disorders are anticipated to boost the growth of the market.

Aldeyra Therapeutics, Inc. announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the H.C. Wainwright Global Investment Conference.

Ensysce Biosciences, Inc. announced the initiation of PF614-103, ‘A Randomized, Double-blind, Placebo- and Active-Controlled Crossover Study to Evaluate the Intranasal Abuse Potential of PF614 Compared with Immediate-Release Oxycodone and Placebo in Non-Dependent Recreational Opioid Users’ is being conducted by Dr. Glen Apseloff, from Ohio Clinical Trials.

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (“4Front” or the “Company”), a vertically integrated, multi-state cannabis operator and retailer, today announced its financial results for the first quarter ended March 31, 2022 (“Q1 2022").

ICON plc, a world-leading healthcare intelligence and clinical research organisation, announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the H.C. Wainwright Global Investment Conference on Tuesday, May 24, 2022, at 7.00am ET.

Transcat, Inc. reported financial results for its fourth quarter and fiscal year ended March 26, 2022.

Genuv Inc. announced it will release new preclinical data at two major medical conferences in June.

CVRx, Inc. announced that the management team will present at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6, 2022.

Cellectis announced that it will hold its combined general meeting on June 28, 2022 at 2:30 p.m. CET at the Company’s offices at 8 rue de la Croix Jarry 75013 Paris, France.

West Pharmaceutical Services, Inc. announced its participation at INTERPHEX 2022 to showcase its leadership and expertise on industry challenges and trends in packaging and containment.